Hiroyuki Abe to Breast Neoplasms
This is a "connection" page, showing publications Hiroyuki Abe has written about Breast Neoplasms.
Connection Strength
5.793
-
Reply to "Differentiating Benign Lesions From Areas of Malignant Nonmass Enhancement With MRI". AJR Am J Roentgenol. 2021 01; 216(1):W8.
Score: 0.295
-
Discrimination of benign from malignant breast lesions in dense breasts with model-based analysis of regions-of-interest using directional diffusion-weighted images. BMC Med Imaging. 2020 06 09; 20(1):61.
Score: 0.284
-
Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation. AJR Am J Roentgenol. 2020 08; 215(2):511-518.
Score: 0.283
-
Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions. AJR Am J Roentgenol. 2018 10; 211(4):933-939.
Score: 0.249
-
Abbreviated MRI and Accelerated MRI for Screening and Diagnosis of Breast Cancer. Top Magn Reson Imaging. 2017 Oct; 26(5):183-189.
Score: 0.235
-
Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH). J Magn Reson Imaging. 2017 12; 46(6):1738-1747.
Score: 0.226
-
Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment. AJR Am J Roentgenol. 2016 Nov; 207(5):1159-1166.
Score: 0.218
-
MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes. J Magn Reson Imaging. 2015 Oct; 42(4):920-4.
Score: 0.197
-
Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer. J Magn Reson Imaging. 2015 Sep; 42(3):771-8.
Score: 0.194
-
Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR Am J Roentgenol. 2014 Feb; 202(2):289-92.
Score: 0.183
-
Decision making for breast lesions initially detected at contrast-enhanced breast MRI. AJR Am J Roentgenol. 2013 Dec; 201(6):1376-85.
Score: 0.180
-
Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound. Acad Radiol. 2013 Nov; 20(11):1399-404.
Score: 0.179
-
Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases. AJR Am J Roentgenol. 2013 Nov; 201(5):1155-63.
Score: 0.179
-
Quantitative ultrasound image analysis of axillary lymph node status in breast cancer patients. Int J Comput Assist Radiol Surg. 2013 Nov; 8(6):895-903.
Score: 0.172
-
Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR Am J Roentgenol. 2013 Mar; 200(3):696-702.
Score: 0.171
-
Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3802.
Score: 0.168
-
MR-directed ("Second-Look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol. 2010 Feb; 194(2):370-7.
Score: 0.138
-
Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients. Radiology. 2009 Jan; 250(1):41-9.
Score: 0.127
-
US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer: why and how to do it. Radiographics. 2007 Oct; 27 Suppl 1:S91-9.
Score: 0.118
-
Role of sureness in evaluating AI/CADx: Lesion-based repeatability of machine learning classification performance on breast MRI. Med Phys. 2024 Mar; 51(3):1812-1821.
Score: 0.088
-
Safely reducing unnecessary benign breast biopsies by applying non-mass and DWI directional variance filters to ADC thresholding. BMC Med Imaging. 2022 09 29; 22(1):171.
Score: 0.083
-
Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform. Breast Cancer Res Treat. 2022 Nov; 196(1):57-66.
Score: 0.083
-
Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy. Acad Radiol. 2022 10; 29(10):1469-1479.
Score: 0.080
-
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
Score: 0.077
-
High-Resolution Full-3D Specimen Imaging for Lumpectomy Margin Assessment in Breast Cancer. Ann Surg Oncol. 2021 Oct; 28(10):5513-5524.
Score: 0.077
-
Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer. 2021 Sep; 28(5):1141-1153.
Score: 0.075
-
Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling. Cancer Imaging. 2019 Jul 15; 19(1):48.
Score: 0.067
-
Low-dose imaging technique (LITE) MRI: initial experience in breast imaging. Br J Radiol. 2019 Nov; 92(1103):20190302.
Score: 0.067
-
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial. J Magn Reson Imaging. 2019 06; 49(6):1617-1628.
Score: 0.063
-
Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density. Acad Radiol. 2019 07; 26(7):e141-e149.
Score: 0.063
-
Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI. Eur Radiol. 2019 Apr; 29(4):1778-1786.
Score: 0.063
-
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology. 2018 12; 289(3):618-627.
Score: 0.063
-
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clin Cancer Res. 2019 03 15; 25(6):1786-1794.
Score: 0.063
-
Lymph node wire localization post-chemotherapy: Towards improving the false negative sentinel lymph node biopsy rate in breast cancer patients. Clin Imaging. 2018 Mar - Apr; 48:69-73.
Score: 0.059
-
Fast bilateral breast coverage with high spectral and spatial resolution (HiSS) MRI at 3T. J Magn Reson Imaging. 2017 11; 46(5):1341-1348.
Score: 0.057
-
Gadobutrol-Enhanced Magnetic Resonance Imaging of the Breast in the Preoperative Setting: Results of 2 Prospective International Multicenter Phase III Studies. Invest Radiol. 2016 07; 51(7):454-61.
Score: 0.054
-
Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis. Acad Radiol. 2016 09; 23(9):1137-44.
Score: 0.054
-
Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0?T: a pilot study. Br J Radiol. 2015 May; 88(1049):20150021.
Score: 0.049
-
Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis. Eur Radiol. 2015 Aug; 25(8):2470-8.
Score: 0.049
-
Using quantitative image analysis to classify axillary lymph nodes on breast MRI: a new application for the Z 0011 Era. Eur J Radiol. 2015 Mar; 84(3):392-397.
Score: 0.048
-
Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer. Breast Cancer. 2015 Sep; 22(5):496-502.
Score: 0.045
-
Axillary staging of breast cancer: what the radiologist should know. Radiographics. 2013 Oct; 33(6):1589-612.
Score: 0.045
-
Observer study of a prototype clinical decision support system for breast cancer diagnosis using dynamic contrast-enhanced MRI. AJR Am J Roentgenol. 2013 Feb; 200(2):277-83.
Score: 0.043
-
A prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):615-22.
Score: 0.041
-
Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. Acad Radiol. 2011 Dec; 18(12):1467-74.
Score: 0.039
-
Evaluation of objective similarity measures for selecting similar images of mammographic lesions. J Digit Imaging. 2011 Feb; 24(1):75-85.
Score: 0.037
-
Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study. Radiology. 2011 Mar; 258(3):696-704.
Score: 0.037
-
Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study. Phys Med Biol. 2010 Oct 07; 55(19):N473-85.
Score: 0.036
-
Breast cancers not detected at MRI: review of false-negative lesions. AJR Am J Roentgenol. 2010 Jun; 194(6):1674-9.
Score: 0.035
-
Multi-modality morphological correlation of axillary lymph nodes. Int J Comput Assist Radiol Surg. 2010 Jul; 5(4):343-50.
Score: 0.035
-
Potential usefulness of similar images in the differential diagnosis of clustered microcalcifications on mammograms. Radiology. 2009 Dec; 253(3):625-31.
Score: 0.034
-
Clinical implementation of a multislice high spectral and spatial resolution-based MRI sequence to achieve unilateral full-breast coverage. Magn Reson Imaging. 2010 Jan; 28(1):16-21.
Score: 0.033
-
DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement? Med Phys. 2008 Jul; 35(7):3102-9.
Score: 0.031
-
Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology. 2007 Dec; 245(3):684-91.
Score: 0.030
-
Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons. J Magn Reson Imaging. 2006 Dec; 24(6):1311-5.
Score: 0.028
-
Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. Magn Reson Imaging. 2007 Jun; 25(5):593-603.
Score: 0.028
-
High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience. AJR Am J Roentgenol. 2006 Jan; 186(1):30-7.
Score: 0.026
-
Cross-sectional relatedness between sentences in breast radiology reports: development of an SVM classifier and evaluation against annotations of five breast radiologists. J Digit Imaging. 2013 Oct; 26(5):977-88.
Score: 0.011